Barbara Lanthaler

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Carnosine treatment in combination with ACE inhibition in diabetic rats

Verena Peters, Eva Riedl, Margarita Braunagel et al. · Regulatory Peptides · 2014 · 41 citations

Medicine, Cardiology, Pharmacology +12

Carnosine metabolism in diabetes is altered by reactive metabolites

Verena Peters, Barbara Lanthaler, Albert Amberger et al. · Amino Acids · 2015 · 36 citations

Life Sciences, Biochemistry, Endocrinology +11

Maternal ABCA1 genotype is associated with severity of Smith–Lemli–Opitz syndrome and with viability of patients homozygous for null mutations

Barbara Lanthaler, Elisabeth Steichen‐Gersdorf, Barbara Kollerits et al. · European Journal of Human Genetics · 2012 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +7

Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study

Roland Arnitz, Markus Stein, Barbara Lanthaler et al. · Therapeutic Advances in Respiratory Disease · 2018 · 28 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17